Attention To Details: Neos' ADHD Portfolio

By: via Benzinga
Neos Therapeutics Inc (NASDAQ: NEOS) shares began tumbling on June 21, despite announcing late on June 20 that the FDA approved its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.